Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Working Groups AHub banner.jpg

image-2024-6-10_13-34-4.png

Working Group Events

Our Working Groups have held

4

four events this year

! From

– from Community Forums to webinars and the bi-annual Data Transparency Events, with more to come.  

Data Transparency Virtual events had a (insert number) attendees during its Winter Event. (insert min summery)

4E9EF1F8-F1A3-4A48-9D5A-4839F54F3F81_1_201_a-20250331-144144.jpegImage Removed

Thank you to all 873 attendees for being part of the Data Transparency Winter Event 2025!

We saw incredible discussions, thought-provoking sessions and inspiring ideas shared, with the aim of fostering a more transparent and collaborative data landscape.

We hope you found the event valuable and engaging. It was a pleasure to provide a platform for innovation, and we’re excited to continue these conversations!

All recordings and presentation slides are available on the PHUSE Advance Hub for your reference and continued learning. Read our Summary Blog for a dive into the event’s key highlights and achievements.

4E9EF1F8-F1A3-4A48-9D5A-4839F54F3F81_1_201_a-20250331-144144.jpegImage Added

image-2024-6-10_13-34-33.png

Community Forums

Real World Evidence

:

RWD for Regulatory Decision-Making: Learnings from Use Cases and Demonstration Projects 

FDA guidance is clear that real-world data (RWD) may be acceptable for regulatory approval when a randomised controlled trial is not feasible and the validity and trustworthiness of the real-world study results are clearly demonstrated. To provide more operationalised guidance for meeting these standards, the presenters will share learnings from FDA use cases and ongoing demonstration projects. 

Emerging Trends & Innovation

:

Responsible AI in a Healthcare System 

As

the use of

artificial intelligence (AI) moves from being a curiosity to a necessity, it is clear that the benefit obtained from using AI models to prioritise care interventions is an interplay of the

model’s

models’ performance, the capacity to intervene, and the benefit/harm profile of the

intervention

interventions. After a brief review of the

kinds of

use cases that AI can serve across

multiple

medical specialties, we will discuss Stanford

Healthcare’s

Health Care’s efforts to shape the adoption of health AI tools to be useful, reliable and fair so

that

they lead to cost-effective solutions that meet healthcare’s needs.

  

 

Webinars

Risk Base Based Quality Management:

Make the Most out Out of Innovation and Ensure it’s Done Right!

Join the webinar to learn why change is not only an idea but a necessity. We will explore where old habits need to be retired and where new initiatives have proven to increase efficiency and reduce cost without impacting on quality. 

This Webinar webinar took place virtually on 20 February 2025.